-
,for, Item ID-
- #1225685
- Providers like you icon 47
- Binx Health #1.002.101
Molecular Reagent binx io® Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) CLIA Waived For io Instrument 50 Tests
ASSAY, CT/NG BINX HEALTH IO SNGL-USE CARTRIDGE (50/CS) D/S
Features
- Single use cartridge (10 Tests per pack, 5 Packs per Case)
- The binx health io CT/NG Assay, when tested using the binx health io Instrument, is a fully automated, rapid, qualitative test intended for use in point-of-care or clinical laboratory settings for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA by polymerase chain reaction
- The binx health io CT/NG test, designed to be performed in the clinic or decentralized laboratory while the patient waits, can enable immediate treatment of positive patients, removing the need for presumptive treatment, improving compliance, and reducing loss to follow-up
- More …
Product Details Email
Product Specifications
McKesson # | 1225685 |
---|---|
Manufacturer # | 1.002.101 |
Brand | binx io® |
Manufacturer | Binx Health |
Country of Origin | Ireland |
Application | Molecular Reagent |
CLIA Classification | CLIA Waived |
CLIA Classified | CLIA Waived |
For Use With | For io Instrument |
Number of Tests | 50 Tests |
Sample Type | Urine / Vaginal Swab Sample |
Specialty | Molecular |
Test Category | Sexual Health |
Test Format | Cartridge |
Test Name | Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) |
Test Type | Molecular Diagnostic |
Time to Results | 30 Minute Results |
UNSPSC Code | 41116011 |
Features
- Single use cartridge (10 Tests per pack, 5 Packs per Case)
- The binx health io CT/NG Assay, when tested using the binx health io Instrument, is a fully automated, rapid, qualitative test intended for use in point-of-care or clinical laboratory settings for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA by polymerase chain reaction
- The binx health io CT/NG test, designed to be performed in the clinic or decentralized laboratory while the patient waits, can enable immediate treatment of positive patients, removing the need for presumptive treatment, improving compliance, and reducing loss to follow-up
- First ever FDA 510(k), CLIA-Waived CT/NG molecular test for males and females, enabling same-visit diagnosis and treatment
- Gives results comparable to a laboratory-based test for chlamydia and gonorrhea in about 30 minutes rather than days or weeks
- The binx health io CT/NG Assay is intended for use with female vaginal swab specimens, collected either by a clinician or self-collected by a patient in a clinical setting, or male urine specimens, as an aid in the diagnosis of symptomatic or asymptomatic Chlamydia trachomatis and/or Neisseria gonorrhoeae infection
Professionals Also Viewed
-
,for, Item ID-
- #1080512
- Providers like you icon 464
- Cepheid #XPRSTREPA-10
- Xpert® Xpress Strep A is a qualitative real-time PCR test providing ac …
- Xpert® Xpress Strep A provides medically actionable and timely informa …
- For In Vitro Diagnostic Use
-
,for, Item ID-
- #1045073
- Providers like you icon 226
- Cepheid #GXCT/NG-10
- 90 minute detection and differentiation of Chlamydia trachomatis (CT) …
-
,for, Item ID-
- #931480
- BD #441124
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collec …
-
,for, Item ID-
- #1177911
- Providers like you icon 105
- Roche #09211101190
- cobas® SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cob …
- Product ships from McKesson with minimum 30 days dating
- The cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the …